AstraZeneca PLC (AZN) — closed signal from January 18, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on April 18, 2026.
Predicted vs. what happened
AZN price · publication thesis → realized outcomesplit-adjusted
$360.38 – $372.13Entry zone — fair-value band
$186.81Published — price the day we called it
$414.11Target — the price the thesis aimed for
$210.50Peak — highest point inside the window, not a realized return
$204.80Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 31 days.
Peak price
$210.50
peak on February 18, 2026 — not a realized returnPeak gain
+12.7%
peak, from the publication priceWindow close
$204.80
end-of-window price, context onlyDays to target
31
Window
January 18, 2026 – April 18, 2026
The thesis — published January 18, 2026
Predicted growth
+12%
over the measurement windowTarget price
$414.11
the price the thesis aimed forEntry zone
$360.38 – $372.13
the fair-value band we waited forPrice at publication
$186.81
published January 18, 2026Confidence
65%
how strongly the data lined upTimeframe
Short-term (0–3 months)
AstraZeneca helps make a portfolio less tied to tech because it is a big healthcare company. Buying Modella AI reinforces its work on cancer drugs using data tools, which could help future research. M&A news may not boost earnings right away, and the sector can move on regulatory or legal updates. Start small and add only if the stock holds strength.
Primary drivers
- Adding healthcare stock can lower correlation with tech holdings
- Modella AI deal supports cancer drug research using data tools
- Large drug makers often fare better when markets get rocky
- Deal work and regulator attention may limit short-term gains
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.